What is the most effective strategy to reduce the risk of stroke recurrence in neoplastic vasculitis?
Treating the underlying malignancy is the most effective strategy to reduce the risk of stroke recurrence thought to be attributable to a neoplastic vasculitis. Angiotropic lymphoma is perhaps the most commonly reported neoplastic vasculitis in the literature. In a large meta-analysis of cases of angiotropic lymphoma reported between 1957 and 2012, only 8% presented with stroke-like symptoms. Therefore, we advise treating the underlying malignancy.